ºÚÁÏÊÓƵ

Background

Gail B. Rattinger received her bachelor's degree in chemistry from Occidental College, Los Angeles, Calif. in 1979, her PhD in physical inorganic chemistry from University of Illinois Champaign-Urbana, Champaign–Urbana, Ill. in 1984, and her Doctor of Pharmacy (PharmD) from University of California, San Francisco, San Francisco, Calif. in 2007. Upon completing her PharmD, she completed a postdoctoral fellowship in pharmacoeconomics and health outcomes at the University of Maryland School of Pharmacy, Baltimore, Md., from 2007−2009. She is a licensed pharmacist in New Jersey and Maryland.

After completing her postdoctoral fellowship, she became assistant professor and director of the pharmaceutical research computing center at the University of Maryland’s School of Pharmacy. In 2012, she joined the School of Pharmacy at Fairleigh Dickinson University in Florham Park, N.J., as an associate professor and director of the pharmacy practice division.

In 2015, she became a founding member of the School of Pharmacy and Pharmaceutical Sciences at ºÚÁÏÊÓƵ, as the associate dean for academic affairs and assessment and professor of health outcomes and administrative sciences. She also served as vice dean of the school for a period of time. She is committed to employing active learning and assessment across healthcare curricula to ensure curricular delivery prepares health professional students to assume significant “top-of license" roles on interprofessional healthcare teams as well as within research organizations.

Her research focuses on unmet healthcare needs of geriatric and other vulnerable populations with an emphasis on dementia, particularly predictors of informal care costs, interventions focused on modifiable factors that impact informal costs, sex differences in the impact of stressful life events and socioeconomic status on lifetime risk factors for dementia as well as opportunities for disease management. She has previously received funding from NIH (K12) as well as state agencies. Recently, she initiated work on the differences in availability of HIV testing and pre-exposure prophylaxis (PReP) prescribing practices in vulnerable populations in urban and rural community settings. She is collaborating with other researchers in studies on the effectiveness of various interventions to treat those with opioid use disorders.

Education

• BA, Occidental College
• PhD, University of Illinois at Urbana-Champaign
• PharmD, University of California at San Francisco
• Postdoctoral fellowship, University of Maryland

Research Interests

• Health outcomes
• neurodegenerative diseases
• Pharmacoepidemiology
• Large-claims databases